Cardio-vascular risk in patients with arterial hypertension: an evolution of views
https://doi.org/10.18705/1607-419X-2009-15-3-314-319
Abstract
Aim of the study. To evaluate the re-stratification of total cardio-vascular risk according Russian guidelines for treatment of arterial hypertension (HT) 2004-2008. Materials and methods. All diagnostic procedures recommended by Russian guidelines for treatment of HT 2004-2008 were applied. Results and conclusions. There were no patients with low added risk in the cohort with newly diagnosed or nontreated HT. According to the previous version of recommendations 69 % of them has high/very high added risk. If new dislipidemia criteria applied, fasting plasma glucose, glucose tolerance test as risk factors included, and metabolic syndrome and low estimated glomerular filtration rate as subclinical organ damage considered 87 % patients could be stratified as high/very high added risk patients. Attention should be paid mainly to the patients with grade I HT and younger than 55 years old.
About the Authors
E. Shavarova
The Russian University of National Friendship
Russian Federation
Russian Federation
E. T. Mufteeva
The Russian University of National Friendship
Russian Federation
Russian Federation
Z. D. Kobalava
The Russian University of National Friendship
Russian Federation
Russian Federation
References
1. Weir M.R. Shifting paradigms in definition and treating hypertension: addressing global risk with combination therapy // J. Clin. Hypertens. - 2008. - Vol. 10 (suppl 1). - P. 2-3.
2.
3. Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertens. - 2003. - Vol. 21. - P. 1011-1053.
4.
5. Mancia G., De Backer G., Dominiczak A. et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC) // J. Hypertens. - 2007. - Vol. 25. - P. 1105-1187.
6.
7. Кобалава Ж.Д., Котовская Ю.В., Виллевальде С.В. Рекомендации по артериальной гипертонии 2007г.: текст, контекст и размышления // Кардиология. - 2008. - T. 2. - C. 72-87.
8.
9. Национальные рекомендации по профилактике, диагностике и лечению артериальной гипертонии (второй пересмотр) // Кардиоваск. тер. и проф. - 2004. - Т. 3, №1. - C. 105-120.
10.
11. Диагностика и лечение артериальной гипертонии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов // Кардиоваск. тер. и проф. 2008 (приложение 2).
12.
13. Moser M. Historical perspectives on the management of hypertension // J. Clin. Hypertens. - 2006. - Vol. 8. - P. 15-20.
14.
15. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and treatment of High Blood Pressure // Hypertension. - 2003. - Vol. 42. - P. 1206-1252.
16.
17. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies // Lancet. - 2002. - Vol. 360. - P. 1903-1913.
18.
19. Rosamond W., Flegal K., Friday G. et al. for the American Heart Association Statistics Committee and Stroke Statistics Committee. Heart disease and stroke statistics - 2007 update: a report from American Heart Association Statistics Committee and Stroke Statistics Committee // Circulation. - 2007. - Vol. 115. - P. e69-e171.
20.
21. Giles T.D., Berk B.C., Black H.R. et al. on behalf of the Hypertension Writing Group. Expanding the definition and classification of hypertension // J. Clin. Hypertens. - 2005. - Vol. 7. - P. 505-512.
22.
23. Dzau V.J., Antman E.M., Black H.R. et al. The cardiovascular disease continuum validated: clinical evidence of improved patients outcomes. Part I: pathophysiology and clinical trial evidence) // Circulation. - 2006. - Vol. 114. - P. 2850-2870.
24.
25. Thomas F., Rudnichi A., Bacri A.-M. et al. Cardiovascular mortality in hypertensive men according to presence of associated risk factors // Hypertension. - 2001. - Vol. 37. - P. 1256-1261.
26.
27. Mancia G., Parati G., Borghi C. et al. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study // J. Hypertens. - 2006. - Vol. 45. - P. 1072-1077.
28.
29. Staessen J.A., Wang J.G., Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003 // J. Hypertens. - 2003. - Vol. 21. - P. 1055-1076.
30.
31. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials // Lancet. - 2000. - Vol. 355. - P. 1955-1964.
32.
33. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials // Lancet. - 2003. - Vol. 362. - P. 1527-1535.
34.
35. World Health Organization/International Society of Hypertension. 2003 WHO/ISH statement on management of hypertension // J. Hypertens. - 2003. - Vol. 21. - P. 1983-1992.
36.
Review
For citations:
Shavarova E., Mufteeva E.T., Kobalava Z.D. Cardio-vascular risk in patients with arterial hypertension: an evolution of views. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(3):314-319. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-3-314-319
Views:
1995
Email this article 